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Abstract
Background: MicroRNAs (miRNAs) are small non-coding RNAs that have been found to play
important roles in silencing target genes and that are involved in the regulation of various normal
cellular processes. Until now their implication in the mammary gland biology was suggested by few
studies mainly focusing on pathological situations allowing the characterization of miRNAs as
markers of breast cancer tumour classes. If in the normal mammary gland, the expression of known
miRNAs has been studied in human and mice but the full repertoire of miRNAs expressed in this
tissue is not yet available.
Results:  To extend the repertoire of mouse mammary gland expressed miRNAs, we have
constructed several libraries of small miRNAs allowing the cloning of 455 sequences. After
bioinformatics' analysis, 3 known miRNA (present in miRbase) and 33 new miRNAs were identified.
Expression of 24 out of the 33 has been confirmed by RT-PCR. Expression of none of them was
found to be mammary specific, despite a tissue-restricted distribution of some of them. No
correlation could be established between their expression pattern and evolutionary conservation.
Six of them appear to be mouse specific. In several cases, multiple potential precursors of miRNA
were present in the genome and we have developed a strategy to determine which of them was
able to mature the miRNA.
Conclusion: The cloning approach has allowed improving the repertoire of miRNAs in the
mammary gland, an evolutionary recent organ. This tissue is a good candidate to find tissue-specific
miRNAs and to detect miRNA specific to mammals. We provide evidence for 24 new miRNA. If
none of them is mammary gland specific, a few of them are not ubiquitously expressed. For the first
time 6 mouse specific miRNA have been identified.
Background
Numerous small non-coding RNAs of 18–25 bases in
length, called microRNAs (miRNAs), have been found to
play important roles in silencing specific target genes.
Recently Vasudevan et al. [1] have shown that miRNAs can
also activate gene expression, inducing translation up-reg-
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ulation of target messager RNAs (mRNAs) on cell cycle
arrest. The total estimated number of reasonably con-
served miRNAs in vertebrates varies from 250 [2] to 600
[3]. In human, Bentwich et al. [4] suggested that the total
number of miRNAs is above 800. The sequences of many
miRNAs are conserved among distantly related organisms
[5], but recent evidences demonstrated the presence of
primate-specific miRNAs [6,7]. miRNAs are transcripts
which are cleaved from a ~70 nucleotides hairpin precur-
sor by Dicer [8,9]. They regulate gene expression at the
posttranscriptional level through binding to their target
mRNAs by base-pairing and subsequently inducing either
translational repression or mRNA destabilization [10].
miRNAs are involved in the regulation of various cellular
processes, including cell differentiation, cell proliferation,
development and apoptosis [11].
Several methods are used to characterize the miRNA
expression profiles in specific tissues such as Northern
blotting, RNase protection assay, RT-PCR and microarray
analyses. All these approaches depend on the prior knowl-
edge of the miRNA sequences. If the accurate profiling of
known miRNA expression represents an important tool to
investigate physiological and pathological states, the dis-
covery of new miRNAs is still important. Bioinformatics'
strategies and miRNA gene prediction algorithms have
been used to screen genome sequences and to identify
potential miRNAs [[2], for review [12]]. Schematically,
the bioinformatic' approaches scan genomic sequences
for the phylogenetic conservation of short nucleotides
motifs located within genomic stretches that have the
structural characteristics, ie secondary structures, of
miRNA precursors. However such gene predictions may
not reveal all miRNAs, and might especially miss those
that are not phylogenetically conserved. Furthermore, all
these in silico predictions require independent experimen-
tal validations. In contrast, the cloning approaches
allowed the identification of miRNAs without prior
knowledge of their sequences [for example [13]], but limit
the identification only to those miRNAs present at specific
moments in the studied organ.
The mammary gland is a dynamic organ whose structure
changes throughout the female reproductive cycle. These
successive physiological stages, that are regulated by hor-
mones, growth factor ligands, their receptors and some
transcriptional factors, are characterized by proliferation,
differentiation and apoptosis of the mammary epithelial
tissue which is embedded in the stroma [for review:
[14,15]].
An implication of miRNAs in mammary gland biology
was suggested by few studies mainly focusing on patho-
logical situations, such as the appearance of breast cancer
[[16] for review]. Some miRNAs were found deregulated
in human breast cancers [17-21]. Recently the role of spe-
cific miRNAs (miR-206, -221 and -222) in the regulation
of the human Estrogen Receptor- in breast cancer cell
lines has been demonstrated [22,23]. Moreover some
miRNAs expression profiles have been used to identify
human breast cancer tumor subclasses [24,25]. In the nor-
mal mammary gland the expression of known miRNAs
has been studied in human [26] and mouse [27,28] at dif-
ferent developmental stages and found to be regulated.
Moreover the identification and characterization of miR-
NAs from the bovine mammary tissue by Gu et al. [29]
allowed the cloning of 33 distinct miRNAs, including 3
novel ones. Recently, Ibarra et al. [30] showed that several
miRNAs are involved in the maintenance of mouse mam-
mary epithelial progenitor cells. The full repertoire of
miRNAs expressed in one tissue, in a specific condition or
in specific cell types is not yet available and could revealed
specific miRNAs. The mammary gland which is an evolu-
tionary recent organ is a good candidate to search for such
tissue-specific miRNAs.
Results and discussion
Cloning of new miRNAs from mouse mammary gland
Using the small RNA cloning method described by Lagos-
Quintana  et al. [31], cDNA libraries were constructed
from RNA samples of mouse mammary glands collected
at different stages (virgin 8 weeks, gestation 2-, 6- and 18-
days, lactation 4-days and involution 1-day). A total of
455 clones were obtained and sequenced, of which 169,
corresponding to 120 non redundant sequences, had
inserts ranging between 18 and 28 nt in length (Addi-
tional file 1). Most of the remaining clones contained
inserts smaller than 17 nt and were not further analysed.
The 120 non redundant sequences were compared with
known miRNAs by searching the miRBase database
(release 12.0). Nine sequences matched with mature miR-
NAs, 3 of them perfectly with mouse let-7b (MG030), let-
7c (MG070) and human miR-923 (MG041) respectively,
3 with a 1-nt difference with mouse miR-126-5p
(MG034), miR-429 (MG018) and human miR-1268
(MG068), and 3 have partial homologies (Additional file
1). Human miR-923 is 100% homologous with the
mouse genomic sequence. The above-mentioned 3
sequences that perfectly matched with known miRNAs
were thus considered as corresponding to true miRNAs
and not further analysed. Thirty-three sequences have par-
tial homologies with 1 or several precursors of different
species, among them 17 have partial homology with the
miRNA strand, 8 with the miRNA* strand and 8 with the
loop (Additional file 1).
One important criteria that distinguishes miRNA from
other endogenous small RNA is the ability of their
genomic flanking sequences to adopt a hairpin structure
with the mature miRNA properly positioned within oneBMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
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of its strand in order to be excised during Dicer processing
[32]. The 117 sequences cloned were aligned with the
mouse genome using BLAST, 31 of them were not found
to be homologous. They were discarded; and considered
as being cloning artefacts. For some of them we cannot
exclude that the mismatches observed are due to RNA
editing [33]. Among the 86 homologous sequences, 15
showed homology with a single location, whereas the
others could be located in several genomic regions, lead-
ing overall to a total of 441 localisations. To assess which
of the 441 regions correspond to potential miRNA genes,
their secondary structures were studied using the RNA
folding program MFOLD [34]. One hundred and fourteen
chromosomal regions, which correspond to 40 cloned
sequences, could form a stable hairpin structure. Among
the 114 chromosomal regions, 57 were annotated as
ribosomal RNA or small nuclear RNA and were discarded.
The 57 remaining corresponded to 33 cloned sequences.
Their chromosomal locations and sequence alignments
revealed that several cloned sequences were partially over-
lapping and could derive from the same precursor. In our
study 5 families, corresponding to 13 sequences, were
detected (Figure 1). Recently, the presence of variants has
been reported after the characterization of cDNA libraries
of small RNAs from porcine fibroblast cells [35] and from
bovine adipose tissue and mammary gland [29]. The 3'-
end variants may thus arise from preferential degradation
at the 3' end or from imprecise processing of miRNA pre-
cursors by Dicer, thereby generating miRNAs with differ-
ing 3' ends [36,37]. However, we cannot exclude the
possibility that these miRNA variants originate from mul-
tiple genomic loci. The functional specialization of
miRNA variants is still unknown. The 33 cloned
sequences could derive from 41 precursors (Additional
file 2). In fact one cloned sequence could derive from sev-
eral precursors (Additional file 2, for example MG141
could be issue from 3 precursors). In some cases one
cloned sequence possess i) 2 identical precursors localised
in 2 different chromosomes (Additional file 2, MG016-13
and -16), ii) 3 identical precursors clustered in one chro-
mosome (MG055) or iii) 2 similar precursors (with 1 or 3
different nt) in two different chromosomes (Additional
file 2, MG009/MG037/MG056/MG066-06 and -17,
MG016-04 and -1 or MG141-12 and -15, for example).
Overall the precursors are distributed on all the chromo-
somes but chromosomes 5, 10 and Y (Figure 2). Chromo-
some 1 appears to contain more mammary gland miRNA
genes than any other chromosome. Our result are in
agreement with published results [38,39] that showed
that miRNA genes are distributed among all the chromo-
somes but chromosome Y. Twenty-six of the precursors
are localised in intergenic regions, 14 in genes (intron: 11,
5'UTR: 1, 3'UTR: 1 and exon: 1) and 1 corresponds to one
Sequence variations of cloned mouse miRNAs Figure 1
Sequence variations of cloned mouse miRNAs. Two to 4 variants were identified for 5 distinct families. The number of 
clones for each variant is indicated in the parentheses beside the sequence. The sequences of the corresponding precursors 
are presented in Additional file 2. For several families, more than one predicted precursors were determined by bioinformatics' 
analysis (Additional file 2).
miRNA  sequence (5’ to 3’) 
 
MG004  GGCGGGTGTTGACGCGATG      (6) 
MG008  GGCGGGTGTTGACGCGATGTGA    (4) 
MG056  TGAGTGTCCCGCGGGGCCCGAA    (1) 
MG037   GAGTGTCCCGCGGGGCCCGAA    (1) 
MG009       GTCCCGCGGGGCCCGAAGCGTT(1) 
MG066     TCCCGCGGGGCCCGAAGCG  (1) 
 
MG017  AGAGGTCTTGGGGCCGAAAC       (1) 
MG145  AGAGGTCTTGGGGCCGAAACGATCT  (2) 
MG117       TCTTGGGGCCGAAACGATCTC (1) 
    
MG071  GACGAGGTGGCCGAGTGGTT    (2) 
MG156  GACGAGGTGGCCGAGTGGTTAAG    (1) 
    
MG113  AGGGGCTCGTCCGAAAGCCG    (2) 
MG130  AGGGGCTCGTCCGAAAGCCGCC    (1) BMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
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miRNA non-fully characterised
(ENSMUSG00000076325) (Additional file 2). Thus the
majority of miRNA genes are part of intergenic sequences
(62%) as observed by Ro et al. [40]. By analysing the prox-
imity of the 57 chromosomal locations in the mouse
genome, 4 miRNA clusters were observed (Table 1). The
miRNA genes are in the same cluster if they are less than
1000 bp apart on the same chromosome [29]. This phys-
ical proximity is consistent with recent reports of miRNA
clustering within the human genome [41]. Among the 4
clusters, 2 correspond to the association of two new pre-
cursors, MG016-01 and MG016-16, with 2 miRNAs
already described mmu-miR-689-1 and mmu-miR-689-2,
respectively (Table 1). The cluster MG055 on chromo-
some 1 has three repeats of the same precursor.
The evolutionary conservation of the 33 new miRNAs (25
distinct miRNAs + 8 variants; Table 2) was studied by
comparison of their sequences with the human, rat, dog,
monkey, chicken, Danio rerio, monodelphis and Orni-
thorhynchus anatinus genome sequences. Only 3 were
conserved in all the species studied. Six were not detected
in any other species (Table 2). If the phylogenetic conser-
vation of the miRNA sequence is one of the criteria estab-
lished by Ambros et al. [32] to characterize miRNA, it is
important to recall that for some species the sequencing of
their genome is not complete enough to detect all the
sequences cloned here. It remains that the bioinformatics'
analysis performed in this study has allowed identifying
mouse specific miRNA.
Expression profiling of the 33 new miRNAs
miRNA expression is generally examined to better under-
stand their physiological function. In this study, the tissue
expression profile was used to assess the mammary gland
specificity of the new miRNAs. In addition these analyses
provide additional evidence for the identification of a
bona fide miRNA. Expression of the 33 new miRNAs
cloned in this study was analysed using an adapted RT-
PCR described by Shi and Chiang [42] and Ro et al. [43]
and detailed in the Methods' section. Using this approach,
we could detect expression for 22 of them in at least one
of the 4 analysed tissues (lactating or involuting mouse
mammary gland, brain, muscle and liver, Figure 3 and
Table 3). Based upon the multi-tissues expression profiles,
these new miRNAs have been grouped into 4 categories:
undetected (11 miRNAs), ubiquitously expressed (10
miRNAs), mammary specific (4 miRNAs), and expression
in several but not all tissues (8 miRNAs). Among the latter
category, one is not expressed in the mammary gland
stages used for the RT-PCR experiment (lactation and
involution).
The expression profile is the same for the 3 miRNAs
present in the cluster MG113/MG130; MG141. The char-
acterization of the undetected miRNAs was completed by
studying their expression in some supplementary mam-
mary gland stages (virgin 8 weeks, gestation day-18 or lac-
tation day-4). Among the 11 miRNAs, only 2 have been
detected (MG004 and MG123, data not shown). Among
the 9 miRNAs undetected 3 correspond to variants of dif-
ferent families. We cannot exclude that these 3 variants are
Chromosomal distribution of the miRNA genes identified in this study Figure 2
Chromosomal distribution of the miRNA genes identified in this study. The number of hits represents the number of 
miRNA genes localized on each chromosome. Thus study did not reveal the occurrence of a specific chromosome encompass-
ing most of the mammary-expressed miRNA loci.BMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
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cloning artefact or that this lack of detection is due to indi-
vidual variation for such miRNA families. In a same fam-
ily all the variants are not expressed in the same tissues. A
first analysis has allowed the identification of 4 mammary
gland specific new miRNAs, to confirm this preliminary
result their expression has been studied by RT-PCR on
more tissues (heart, intestine, ovary, lung, spleen and kid-
ney). Finally they were found not to be mammary gland
specific: MG013 is expressed in all the tissues except kid-
ney and heart; and MG056 is expressed in all the tissues
except in ovary and kidney; MG119 have been detected in
all tissues. MG009 was only found to be expressed in
spleen and mammary gland.
In 11 cases the miRNA is detected in mammary gland in
involution but not in lactation, a result in agreement with
the expression profile of known miRNAs at different
stages of the mammary gland biology obtained in our
team (unpublished results). However, no correlation has
been observed between the tissue-distribution of the
miRNA expression (Table 3) and their evolutionary con-
servation (Table 2), or between their mammary expres-
sion profile (Table 3) and their conservation in mammals
Table 1: Four new miRNA gene clusters.
cluster chromosome locations
MG016 and mmu-miR-689-1 Chr 1: 169270471–169270525 and 169270532–169270640
MG055a; b and c Chr 1: 172996751–172996851, 173004422–173004522, 173011996–173012096
MG113/MG130; MG141 Chr 12: 1008832575–100883333, 100883323–100883403
mmu-miR-689–2 and MG016 Chr16: 11144133–11144241 and 11144248–11144304
Table 2: Conservation of the 33 new miRNAs in other species.
name Ra Hu Do Or Mo Ch DR Md
MG004/MG008 0 x 0 0 x x x 0
MG009/MG037/MG056/MG066 0 0 x x 0 x 0 x
MG013 0 x x x x x x x
MG016 0 0 0 0 x 0 0 0
MG017/MG117/MG145 0 x 0 0 x x 0 0
MG023 0 0 0 0 0 0 0 0
MG039 0 0 0 0 0 0 0 0
MG053 0 0 0 0 0 0 0 0
MG054 x x 0 0 x x 0 x
MG055 x x x 0 x 0 x x
MG057 0 0 0 0 0 0 0 0
MG059 x x 0 0 x 0 0 x
MG071/MG156 x x x x x x x x
MG112 x x x 0 x x x x
MG113/MG130 0 0 0 0 0 0 0 0
MG119 x x x 0 x x 0 0
MG121 x x x x x x x x
MG123 x x x x x x x x
MG125 x x x x x x 0 x
MG127 x x 0 0 x x 0 x
MG141 0 0 x 0 x 0 0 0
MG143 0 0 0 0 0 0 0 x
MG144 x x 0 0 x x x x
MG147 0 x x 0 x 0 x x
MG155 x x x 0 x x x x
0: non detected, x: detected
Ra, rat; Hu, human; Do, Dog; Or, ornithorhynch; Mo, monkey; Ch, chicken; DR, Danio Rerio; Md, Monodelphis.BMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
Page 6 of 10
(page number not for citation purposes)
(Table 2). And the 6 miRNAs present only in the mouse
genome are expressed in the 4 tissues tested. If in this
study no mammary gland specific miRNA have been iden-
tified, several new miRNAs which are not ubiquitously
expressed have been cloned.
Functional validation of precursors detected by 
bioinformatics' analysis
The bioinformatics' analysis allowed the detection of
potential precursors, but these results could not deter-
mine if these hairpin structures will be matured by RNase
III, Drosha in the nucleus and Dicer in the cytoplasm. The
use of expression vectors in cell culture, allowing the syn-
thesis of hairpin structures that are matured into miRNAs,
has already been demonstrated [44,45]. To test the func-
tional validity of the precursors obtained by bioinformat-
ics' analysis, we expressed them in transfected cells and
checked for the presence of the mature miRNAs. The con-
structs carrying the precursors (MG008-X and MG053-01)
were transiently transfected in COS-7 cells and the expres-
sion of the mature miRNAs (MG008 and MG053) was
studied by Northern blot analysis (Figure 4). As a control
the precursor of a known miRNA (let-7b) was used (data
not shown). This approach could be used to validate pre-
cursor(s) of miRNA.
Conclusion
In spite of the development of new tools, as the miRNA
arrays, the cloning approaches remain the only strategy to
identify miRNAs in a tissue at a specific stage. As the mam-
Expression of new miRNAs in different tissues Figure 3
Expression of new miRNAs in different tissues. RT-PCR analysis (+, with reverse transcriptase; -, without reverse tran-
scriptase) of newly miRNAs in brain (B), liver (L), muscle (M) and mammary gland (MG) during lactation (day-10, L10) and invo-
lution (day-3, I03) were presented for 6 miRNAs. C samples without cDNA. ma: DNA marker. It is the 1-kb ladder from 
Gibco-BRL and it is shown using two different UV-light intensities to allow its better visualization.BMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
Page 7 of 10
(page number not for citation purposes)
mary gland is an evolutionary recent organ, it is a good
candidate to search for new tissue-specific miRNAs. Our
study provides evidence for the occurrence in this tissue of
3 already known miRNAs and of 33 new mouse miRNAs.
Among the 33 new miRNAs, the expression of 24 of them
was confirmed by RT-PCR analysis.
If none of them is mammary gland specific, some are not
ubiquitous and are good candidates to further analyse
their roles in the mammary gland biology.
One of the rules proposed by Ambros et al. [32] to charac-
terize a miRNAs is the phylogenic conservation of the
miRNA sequences. In our study, no correlation could be
established between the expression and the evolutionary
conservation of these new miRNAs. Our result is in agree-
ment with the data obtained by Berezikov et al. [7] show-
ing by comparing the miRNA content of human and
chimpanzee brain that evolution of miRNAs is an ongo-
ing process and that along with ancient, highly conserved
miRNAs, there are a number of emerging miRNAs. Farh et
al. [46] have suggested that the binding sites of miRNAs to
3'UTR do not necessarily have to be conserved among the
different species. Therefore the miRNAs identified here
that are conserved in non mammalian species could have
also a specific role in the mammary gland, as the others.
Expression in the different stages of the mammary gland
biology and target identification of these new miRNAs
will be critical for determining their functions.
This study has allowed the identification of 6 mouse spe-
cific miRNAs, reinforcing the yet unique ability of the
cloning approach to identify such evolutionary not con-
served miRNAs.
Methods
Collection of samples
The tissues were isolated from FVB/N mice. The mammary
glands were collected at different stages: virgin 8 weeks,
gestation 2-, 6- and 18-days, lactation 3- and 4-days and
involution 1- and 3-day. For all pregnancy samples, day 0
of pregnancy is the day we observed the vaginal plug. Day
1 of involution was designated as 24 h after the removal
of the pups. All mouse manipulations were done follow-
Table 3: Expression profile of the 33 new miRNA.
Brain Liver Muscle MG-L10d MG-I03d
MG004 0 0 0 0 0
MG008 x x x x x
MG009 0 0 0 0 x
MG037 0 x 0 0 x
MG056 0 0 0 0 x
MG066 0 0 0 0 0
MG013 0 0 0 0 x
MG016 x x x x x
MG017 x x 0 0 x
MG117 0 0 0 0 0
MG145 0 0 0 0 0
MG023 x x x x x
MG039 x x x x x
MG053 x x x x x
MG054 x x x x x
MG055 x x 0 0 x
MG057 x x 0 0 0
MG059 0 0 0 0 0
MG071 x 0 0 0 x
MG156 x 0 0 0 x
MG112 0 0 0 0 0
MG113 x x x x x
MG130 x x x x x
MG119 0 0 0 0 x
MG121 0 0 0 0 0
MG123 0 0 0 0 0
MG125 x x x x x
MG127 0 0 0 0 0
MG141 x x x x x
MG143 0 0 0 0 0
MG144 0 0 0 0 0
MG147 x x x 0 x
MG155 x 0 0 x x
0: non detected, x: detected
Functional validation of precursors MG008-X and MG053-01 Figure 4
Functional validation of precursors MG008-X and 
MG053-01. Detection of miRNAs MG008 and MG053 after 
transfection of COS-7 cell with expression vectors vMG008 
and vMG053 by Northern blot analysis. RNAs were 
extracted from cells transfected with expression vectors (T) 
and with the control empty vector (C), separated onto a 15% 
denaturing PAGE and transferred onto a nylon membrane 
Blots were hybridized with miRNA antisense oligonucle-
otides and a U6 probe used as an internal loading control.
BMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
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ing the French Commission de Génie Génétique recom-
mendations.
Small RNA isolation and cloning
For the library construction, small RNAs were isolated
using mirVanaTMP miRNA isolation kit (Ambion) accord-
ing the manufacturer's instructions. Small RNA cloning
was performed as described by Lagos-Quintana et al. [31]
without the step of concatemerization of the PCR prod-
ucts. Briefly, 500 g of RNA were size fractionated using
15% denaturing polyacrylamide gel electrophoresis
(PAGE). Excised gel bands were homogenized in NaCl 0.3
M overnight at 4°C to solubilize RNA. 3' adapter (5' phos-
phorylated) was ligated to the RNA fraction in presence of
T4 RNA ligase (Amersham-Pharmacia). The mix was size
fractionated using 15% PAGE and a 5' adapter was ligated.
The sample was again size fractionated using 15% PAGE
before to be reverse transcribed using primer complemen-
tary to the 3' adapter sequence and PCR amplified using
primers on both adapters. Amplified products were
cloned using pGEM-T vector system I (Promega). Clones
with inserts were sequenced.
Bioinformatics' analysis
Small RNA sequences ranging between 18 and 25-nt in
length obtained from the libraries were multi-aligned by
CLUSTAL W software [47] to exclude redundant
sequences [48]. The distinct sequences were used to search
in miRBase [49] with BLASTN to identify conserved
miRNA [50]. The sequences were mapped in the mouse
genome from EnsEMBL mouse genome database [51]. A
fragment of ~260 nucleotides genomic sequence flanking
the small RNA at both 5' and 3' ends was used for predict-
ing the secondary structure of the miRNA precursor (stem-
loop formations) using the MFOLD program (version
3.2) [34,52]. If a sequence including a small RNA formed
a stem-loop, if the small RNA size ranged from 18–25 nt
and had not been registered in the miRBase, we classified
it as a new miRNA. The sequences of the new miRNA can-
didates and their precursors were subjected to a BLASTN
search against NCBI genomes to estimate the species con-
servation.
miRNA expression analysis
Total RNAs were isolated from tissue samples and from
COS cells using the RNA NOW kit (Biogentex inc.)
according to the manufacturer's protocol with a small
modification. The RNAs were precipitated at -20°C over-
night by the addition of 3 volumes of ethanol. An equal-
molar mix of total RNA from 3 different mice was used for
reverse transcription.
Detection of miRNAs by RT-PCR has been realized after
addition of linkers to the retro-transcribed RNA before
amplification [42,43]. Briefly, 5 g of total RNA were
polyadenylated according to Ambion's protocol (polyA
Polymerase, Ambion, Applied Biosystems, France). The
polyadenylated RNAs were reverse transcribed with a
polyT adapter composed of a polyT sequence and a uni-
versal oligonucleotide
(5'CGAATTCTAGAGCTCGAGGCAGGCGACATGGCTGG
CTAGTTAAGCTTGGTACCGAGCTCGGATC-
CACTAGTCC(T)25(ACG)(ACGT)3'). Detection was
achieved by PCR using a set of primers composed of the
universal primer corresponding to the 5' end of the polyT-
adapter (5'CGAATTCTAGAGCTCGAGGCAGG3') and a
primer specific of the miRNA sequence (Additional file 3).
Reaction products were separated on 2% agarose gel. The
detection of miRNA let-7c has been used as positive con-
trol and was indeed detected in all analysed samples (data
not shown).
For Northern blot analysis, 20 g of total RNA were frac-
tionated using a 15% PAGE, transferred to Hybond-N+
membrane (Amersham) by capillarity. Blots were hybrid-
ized overnight at 55°C with radioactively [-32P]ATP
labeled DNA oligonucleotide probe complementary to
miRNA sequences in Phosphate buffer [53], washed twice
with 2×SSC at 55°C, and exposed to Phosphor Screen and
the StormScan software.
Vector design
The precursor vectors contain the sequences design from
MG008 and MG053 precursors (sequence in bold in
Additional file 2). For MG053 precursor, the oligonucle-
otides sense
(5'CGGGATCCCGAGCGCCGAATCCCCGCCGCGCGTC
GCGGCGTG3') and antisense
(5'CGGGATCCCGGGTCTTCCGTACGCCACATTTCCCAC
GCCGCGACGCGCGGCGG3') were annealed, filled with
the Klenow fragment enzyme and digested by BamHI. The
resulting fragment was inserted into the BamHI site of the
pUHD10.3 plasmid [54]. The MG008 precursor fragment
was obtained by PCR on mouse genomic DNA using the
primer sense
(5'CGGGATCCCGGTTTCAAAGTTTTGATAGGTTCTACGC
ATG3') and antisense
(5'CGGGATCCCGGCTTCAGCTTTGACTTTCAGAGCACT
GGG3') and digested by BamHI before to be cloned into
the BamHI site of the pUHD10.3 plasmid. The orientation
of the insert was characterized by PCR using the primer
sense of the precursor and the primer of the plasmid
design in each side of the cloning site (primer rtTA/1:
5'GATGCCCTGGAATTGACGAG3'  and primer glob/2:
5'TATAACATGAATTTTTCAATAGCG3'). In these vectors,
the precursor is placed under the transcriptional regula-
tion of the CMV promoter, already validated in COS-7 cell
culture (personal communication).BMC Genomics 2009, 10:149 http://www.biomedcentral.com/1471-2164/10/149
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Cell culture experiments
COS-7 cell were cultured in Dulbecco's Modified Eagle's
medium (DMEM) with addition of 10% fetal calf serum,
2 mM glutamine, penicillin 10 U/l and streptomycin
100 U/l at 37°C (5% of CO2). The expression vectors
were transfected using the jetPEI™ cationic reagent (Poly-
Plus transfection) following the manufacturer's instruc-
tions. Cells were harvested 48 h after transfection.
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